Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tetrandrine Tablets Used in Hospitalized Adults With COVID-19: a Double-blind, Placebo-controlled, Randomised Trial

NCT05697029 is registered in ClinicalTrials.gov with Peking University Third Hospital as lead sponsor.

NCT NCT05697029
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05697029 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tetrandrine Tablets Used in Hospitalized Adults With COVID-19: a Double-blind, Placebo-controlled, Randomised Trial
Lead sponsor
Peking University Third Hospital
Phase
Phase 4
Overall status
Withdrawn
Start date
December 31, 2023
Completion date
December 12, 2025
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19